<p>The present invention relates to a nanosuspension of abiraterone acetate or a pharmaceutically acceptable salt, hydrate or solvate thereof and a method of preparing the same. It further relates to a pharmaceutical composition comprising a nanosuspension of abiraterone acetate or a pharmaceutically active salt, hydrate or solvate thereof, and a method of preparing the same.</p>
